| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 7.4% | $32,978,662 | 1,276,595 | BVF PARTNERS L P/IL | 01 Jul 2025 | |||
| SUSQUEHANNA SECURITIES, LLC | 6.3% | $70,320,662 | 1,235,864 | Susquehanna Portfolio Strategies, LLC | 30 Sep 2025 | |||
| VANGUARD GROUP INC | 5% | +1.2% | $43,425,528 | +$3,316,543 | 1,027,089 | +8.3% | The Vanguard Group | 31 Dec 2025 |
| INTEGRATED CORE STRATEGIES (US) LLC | 3% | -48% | $32,489,559 | -$20,590,346 | 570,994 | -39% | Millennium Management LLC | 30 Sep 2025 |
| Nantahala Capital Management, LLC | 2.2% | -59% | $23,813,902 | -$16,571,499 | 418,522 | -41% | Nantahala Capital Management, LLC | 30 Sep 2025 |
| BlackRock, Inc. | 1.6% | $5,245,655 | 203,017 | BlackRock, Inc. | 30 Jun 2025 |
As of 30 Sep 2025, 142 institutional investors reported holding 14,405,773 shares of NEKTAR THERAPEUTICS - Common Stock (NKTR). This represents 71% of the company’s total 20,378,750 outstanding shares.
The largest institutional shareholders of NEKTAR THERAPEUTICS - Common Stock (NKTR) together control 54% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BVF INC/IL | 6.3% | 1,276,595 | 2.9% | $72,638,256 | |
| VANGUARD GROUP INC | 4.7% | 948,647 | +30% | 0% | $53,978,015 |
| MORGAN STANLEY | 4.6% | 929,151 | +1188% | 0% | $52,868,691 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4.5% | 924,896 | +317% | 0.08% | $52,626,582 |
| FARALLON CAPITAL MANAGEMENT LLC | 3.9% | 791,000 | 0.25% | $45,007,900 | |
| BlackRock, Inc. | 3% | 609,114 | +47% | 0% | $34,658,587 |
| MILLENNIUM MANAGEMENT LLC | 2.7% | 545,994 | -16% | 0.02% | $31,067,059 |
| TWO SIGMA INVESTMENTS, LP | 2.1% | 434,237 | +447% | 0.04% | $24,708,085 |
| Nantahala Capital Management, LLC | 2.1% | 418,522 | -41% | 1.5% | $23,813,902 |
| CITADEL ADVISORS LLC | 1.8% | 361,073 | 0.02% | $20,545,053 | |
| 22NW, LP | 1.6% | 331,115 | +127% | 9.8% | $18,840,443 |
| EMERALD ADVISERS, LLC | 1.6% | 323,246 | 0.59% | $18,392,697 | |
| Jefferies Financial Group Inc. | 1.5% | 303,200 | 0.16% | $17,252,080 | |
| GREAT POINT PARTNERS LLC | 1.5% | 300,000 | 7.1% | $17,070,000 | |
| PRIMECAP MANAGEMENT CO/CA/ | 1.4% | 289,050 | -3.6% | 0.01% | $16,446,945 |
| RENAISSANCE TECHNOLOGIES LLC | 1.4% | 278,541 | +13% | 0.02% | $15,848,983 |
| ARMISTICE CAPITAL, LLC | 1.3% | 268,000 | +116% | 0.48% | $15,249,200 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.1% | 233,205 | 0.69% | $13,269,365 | |
| Woodline Partners LP | 1.1% | 233,059 | -5.3% | 0.06% | $13,261,057 |
| Invesco Ltd. | 1.1% | 226,897 | +608% | 0% | $12,910,443 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 225,236 | +70% | 0% | $12,821,388 |
| GILDER GAGNON HOWE & CO LLC | 1.1% | 224,828 | +678% | 0.13% | $12,792,713 |
| Balyasny Asset Management L.P. | 0.9% | 182,814 | -53% | 0.02% | $10,402,117 |
| TWO SIGMA ADVISERS, LP | 0.88% | 178,908 | 0.02% | $10,179,865 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.84% | 171,776 | 0.03% | $9,774,054 |